Company Encyclopedia
View More
name
INVO Fertility
IVF.US
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. It also operates fertility clinics, including INVO Centers.
1.380 T
IVF.USMarket value -Rank by Market Cap -/-

Financial Score

17/12/2025 Update
C
Health Care EquipmentIndustry
Industry Ranking106/171
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE122.69%A
    • Profit Margin-417.01%E
    • Gross Margin35.82%C
  • Growth ScoreD
    • Revenue YoY-11.73%E
    • Net Profit YoY-128.30%E
    • Total Assets YoY1101.17%A
    • Net Assets YoY140.31%A
  • Cash ScoreD
    • Cash Flow Margin-23.77%D
    • OCF YoY-11.73%E
  • Operating ScoreB
    • Turnover0.68B
  • Debt ScoreD
    • Gearing Ratio68.94%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    INVO Fertility Inc. Announces Date for Upcoming Special Meeting of Stockholders

    INVO Fertility Inc. will hold a virtual special meeting of stockholders on January 22, 2026, to vote on amending Article IV, Section (a) of the company's Articles of Amendment regarding authorized shares, and other business matters. The announcement was made via EDGAR by the U.S. SEC on December 08, 2025.

    Reuters·
    US
    IVF
    -0.84%
    Reuters·
    US
    IVF
    -0.84%

    Director Matthew K. Szot Reports Disposal of Invo Fertility Inc. Common Shares

    Matthew K. Szot, Director of INVO Fertility, Inc., reported the disposal of common shares of the company. This information was published via EDGAR by the U.S. Securities and Exchange Commission on December 5, 2025. The news is generated by Public Technologies using AI and is for informational purposes only.

    Reuters·
    US
    IVF
    -0.84%
    Reuters·
    US
    IVF
    -0.84%

    INVO Fertility Enacts 1-for-8 Reverse Stock Split

    INVO Fertility Inc. will implement a 1-for-8 reverse stock split effective November 28, 2025. The company's common stock will continue to trade under the symbol “IVF” with a new CUSIP number 44984F807. Approximately 1,891,151 shares will be outstanding post-split. This information was published via EDGAR by the U.S. SEC on December 03, 2025.

    Reuters·
    US
    IVF
    -0.84%
    Reuters·
    US
    IVF
    -0.84%

    INVO Fertility Raises $4 Million in Private Placement

    INVO Fertility Inc. announced a $4 million private placement with an institutional investor, issuing 2,366,864 shares of common stock and warrants for 4,733,728 shares at $1.69 per share. The warrants are exercisable upon shareholder approval and expire in five years. Maxim Group LLC is the sole placement agent. Gross proceeds are expected to be $4 million before fees and expenses.

    Reuters·
    US
    IVF
    -0.84%
    Reuters·
    US
    IVF
    -0.84%

    INVO Fertility Announces Intent to Acquire Indiana-Based Fertility Clinic “Family Beginnings” | IVF Stock News

    INVO Fertility announced its intent to acquire Family Beginnings, a fertility clinic in Indiana, as part of its national expansion strategy. This acquisition aims to enhance INVO's clinical capabilities and broaden access to fertility care in the Midwest. The acquisition is subject to customary due diligence and final agreements. INVO plans to introduce expanded treatment options and integrate digital tools at Family Beginnings. This move aligns with INVO's mission to make fertility care more accessible and patient-centered.

    StockTitan·
    US
    IVF
    -0.84%
    StockTitan·
    US
    IVF
    -0.84%
    © 2025 Longbridge｜Disclaimer